Cargando…

A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set

BACKGROUND: Low back pain (LBP) is one of the most disabling and costly disorders affecting modern society, and approximately 90% of patients are labelled as having non-specific LBP (NSLBP). Several interventions for patients with NSLBP have been assessed in clinical trials, but heterogeneous report...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiarotto, Alessandro, Terwee, Caroline B, Deyo, Richard A, Boers, Maarten, Lin, Chung-Wei Christine, Buchbinder, Rachelle, Corbin, Terry P, Costa, Leonardo OP, Foster, Nadine E, Grotle, Margreth, Koes, Bart W, Kovacs, Francisco M, Maher, Chris G, Pearson, Adam M, Peul, Wilco C, Schoene, Mark L, Turk, Dennis C, van Tulder, Maurits W, Ostelo, Raymond W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308079/
https://www.ncbi.nlm.nih.gov/pubmed/25540987
http://dx.doi.org/10.1186/1745-6215-15-511
_version_ 1782354545152622592
author Chiarotto, Alessandro
Terwee, Caroline B
Deyo, Richard A
Boers, Maarten
Lin, Chung-Wei Christine
Buchbinder, Rachelle
Corbin, Terry P
Costa, Leonardo OP
Foster, Nadine E
Grotle, Margreth
Koes, Bart W
Kovacs, Francisco M
Maher, Chris G
Pearson, Adam M
Peul, Wilco C
Schoene, Mark L
Turk, Dennis C
van Tulder, Maurits W
Ostelo, Raymond W
author_facet Chiarotto, Alessandro
Terwee, Caroline B
Deyo, Richard A
Boers, Maarten
Lin, Chung-Wei Christine
Buchbinder, Rachelle
Corbin, Terry P
Costa, Leonardo OP
Foster, Nadine E
Grotle, Margreth
Koes, Bart W
Kovacs, Francisco M
Maher, Chris G
Pearson, Adam M
Peul, Wilco C
Schoene, Mark L
Turk, Dennis C
van Tulder, Maurits W
Ostelo, Raymond W
author_sort Chiarotto, Alessandro
collection PubMed
description BACKGROUND: Low back pain (LBP) is one of the most disabling and costly disorders affecting modern society, and approximately 90% of patients are labelled as having non-specific LBP (NSLBP). Several interventions for patients with NSLBP have been assessed in clinical trials, but heterogeneous reporting of outcomes in these trials has hindered comparison of results and performance of meta-analyses. Moreover, there is a risk of selective outcome reporting bias. To address these issues, the development of a core outcome set (COS) that should be measured in all clinical trials for a specific health condition has been recommended. A standardized set of outcomes for LBP was proposed in 1998, however, with evolution in COS development methodology, new instruments, interventions, and understanding of measurement properties, it is appropriate to update that proposal. This protocol describes the methods used in the initial step in developing a COS for NSLBP, namely, establishing a core domain set that should be measured in all clinical trials. METHODS/DESIGN: An International Steering Committee including researchers, clinicians, and patient representatives from four continents was formed to guide the development of this COS. The approach of initiatives like Core Outcome Measures in Effectiveness Trials (COMET) and Outcome Measures in Rheumatology (OMERACT) was followed. Participants were invited to participate in a Delphi study aimed at generating a consensus-based core domain set for NSLBP. A list of potential core domains was drafted and presented to the Delphi participants who were asked to judge which domains were core. Participant suggestions about overlap, aggregation, or addition of potential core domains were addressed during the study. The patients’ responses were isolated to assess whether there was substantial disagreement with the rest of the Delphi panel. A priori thresholds for consensus were established before each Delphi round. All participants’ responses were analysed from a quantitative and qualitative perspective to ascertain that no substantial discrepancies between the two approaches emerged. DISCUSSION: We present the initial step in developing a COS for NSLBP. The next step will be to determine which measurement instruments adequately cover the domains.
format Online
Article
Text
id pubmed-4308079
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43080792015-01-28 A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set Chiarotto, Alessandro Terwee, Caroline B Deyo, Richard A Boers, Maarten Lin, Chung-Wei Christine Buchbinder, Rachelle Corbin, Terry P Costa, Leonardo OP Foster, Nadine E Grotle, Margreth Koes, Bart W Kovacs, Francisco M Maher, Chris G Pearson, Adam M Peul, Wilco C Schoene, Mark L Turk, Dennis C van Tulder, Maurits W Ostelo, Raymond W Trials Study Protocol BACKGROUND: Low back pain (LBP) is one of the most disabling and costly disorders affecting modern society, and approximately 90% of patients are labelled as having non-specific LBP (NSLBP). Several interventions for patients with NSLBP have been assessed in clinical trials, but heterogeneous reporting of outcomes in these trials has hindered comparison of results and performance of meta-analyses. Moreover, there is a risk of selective outcome reporting bias. To address these issues, the development of a core outcome set (COS) that should be measured in all clinical trials for a specific health condition has been recommended. A standardized set of outcomes for LBP was proposed in 1998, however, with evolution in COS development methodology, new instruments, interventions, and understanding of measurement properties, it is appropriate to update that proposal. This protocol describes the methods used in the initial step in developing a COS for NSLBP, namely, establishing a core domain set that should be measured in all clinical trials. METHODS/DESIGN: An International Steering Committee including researchers, clinicians, and patient representatives from four continents was formed to guide the development of this COS. The approach of initiatives like Core Outcome Measures in Effectiveness Trials (COMET) and Outcome Measures in Rheumatology (OMERACT) was followed. Participants were invited to participate in a Delphi study aimed at generating a consensus-based core domain set for NSLBP. A list of potential core domains was drafted and presented to the Delphi participants who were asked to judge which domains were core. Participant suggestions about overlap, aggregation, or addition of potential core domains were addressed during the study. The patients’ responses were isolated to assess whether there was substantial disagreement with the rest of the Delphi panel. A priori thresholds for consensus were established before each Delphi round. All participants’ responses were analysed from a quantitative and qualitative perspective to ascertain that no substantial discrepancies between the two approaches emerged. DISCUSSION: We present the initial step in developing a COS for NSLBP. The next step will be to determine which measurement instruments adequately cover the domains. BioMed Central 2014-12-26 /pmc/articles/PMC4308079/ /pubmed/25540987 http://dx.doi.org/10.1186/1745-6215-15-511 Text en © Chiarotto et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Chiarotto, Alessandro
Terwee, Caroline B
Deyo, Richard A
Boers, Maarten
Lin, Chung-Wei Christine
Buchbinder, Rachelle
Corbin, Terry P
Costa, Leonardo OP
Foster, Nadine E
Grotle, Margreth
Koes, Bart W
Kovacs, Francisco M
Maher, Chris G
Pearson, Adam M
Peul, Wilco C
Schoene, Mark L
Turk, Dennis C
van Tulder, Maurits W
Ostelo, Raymond W
A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set
title A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set
title_full A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set
title_fullStr A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set
title_full_unstemmed A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set
title_short A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set
title_sort core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308079/
https://www.ncbi.nlm.nih.gov/pubmed/25540987
http://dx.doi.org/10.1186/1745-6215-15-511
work_keys_str_mv AT chiarottoalessandro acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT terweecarolineb acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT deyoricharda acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT boersmaarten acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT linchungweichristine acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT buchbinderrachelle acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT corbinterryp acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT costaleonardoop acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT fosternadinee acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT grotlemargreth acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT koesbartw acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT kovacsfranciscom acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT maherchrisg acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT pearsonadamm acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT peulwilcoc acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT schoenemarkl acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT turkdennisc acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT vantuldermauritsw acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT osteloraymondw acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT chiarottoalessandro coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT terweecarolineb coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT deyoricharda coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT boersmaarten coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT linchungweichristine coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT buchbinderrachelle coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT corbinterryp coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT costaleonardoop coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT fosternadinee coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT grotlemargreth coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT koesbartw coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT kovacsfranciscom coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT maherchrisg coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT pearsonadamm coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT peulwilcoc coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT schoenemarkl coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT turkdennisc coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT vantuldermauritsw coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset
AT osteloraymondw coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset